Abstract
A small subset of lung adenocarcinomas harbour ROS1 gene arrangements and are amenable to tyrosine kinase inhibitor therapy. Current practice in Austr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
